Biomea Fusion BMEA
NASDAQ BMEA
$0.70 -0.03 (-4.32%)
As of: Oct 21, 2026 · 10:05 AM EDT

Biomea Fusion (BMEA) Other Operating Expenses (2025)

Updated

Biomea Fusion (BMEA) recorded Other Operating Expenses of $2.21 million in FY2025.

Analysis

Biomea Fusion (BMEA) Other Operating Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn
10 Biomea Fusion 51.38 Mn -130.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.21 Mn
API Access

Biomea Fusion Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BMEA&period=max&api_key=YOUR_API_KEY